We are live on ! Find out more
EVGN icon

Evogene
EVGN

35 hedge funds and large institutions have $2.73M invested in Evogene in 2023 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 10 increasing their positions, 5 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

350% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 2

260% more capital invested

Capital invested by funds: $760K → $2.73M (+$1.98M)

100% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 5

25% more funds holding

Funds holding: 28 → 35 (+7)

0.76% more ownership

Funds ownership: 0.17% → 0.93% (+0.76%)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $1K

Holders
35
Holders Change
+7
Holders Change %
+25%
% of All Funds
0.56%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
10
Reduced
5
Closed
2
Calls
–
Puts
$1K
Net Calls
-$1K
Net Calls Change
-$67K

Top Buyers

Rank Fund Capital Flow
1
SCM
Silverarc Capital Management
Massachusetts
+$2.63M
2
Walleye Capital
Walleye Capital
New York
+$453K
3
CH
CVI Holdings
Delaware
+$229K
4
Morgan Stanley
Morgan Stanley
New York
+$42.9K
5
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
+$34.3K

Top Sellers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
-$29.4K
2
VF
Virtu Financial
New York
-$13.8K
3
QC
Quent Capital
New York
-$12.8K
4
Group One Trading
Group One Trading
Illinois
-$1.32K
5
Osaic Holdings
Osaic Holdings
Arizona
-$438
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
1
Silverarc Capital Management
Massachusetts
$1.82M +$2.63M +300,000 +3,000%
Walleye Capital
2
Walleye Capital
New York
$303K +$453K +51,709 New
CH
3
CVI Holdings
Delaware
$153K +$229K +26,164 New
Morgan Stanley
4
Morgan Stanley
New York
$103K +$42.9K +4,902 +39%
LPL Financial
5
LPL Financial
California
$39.2K +$219 +25 +0.4%
BNP Paribas Financial Markets
6
BNP Paribas Financial Markets
France
$38.6K +$34.3K +3,920 +147%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$34.6K – – –
SPC
8
Sigma Planning Corp
Michigan
$29.9K +$5.3K +605 +13%
Renaissance Technologies
9
Renaissance Technologies
New York
$27K – – –
UBS Group
10
UBS Group
Switzerland
$21.1K +$6.12K +699 +24%
PNC Financial Services Group
11
PNC Financial Services Group
Pennsylvania
$21.1K +$31.5K +3,600 New
JP Morgan Chase
12
JP Morgan Chase
New York
$20.7K +$30.9K +3,526 New
CAG
13
Csenge Advisory Group
Florida
$18K +$175 +20 +0.7%
JIC
14
Joel Isaacson & Co
New York
$17.8K – – –
Citadel Advisors
15
Citadel Advisors
Florida
$16.1K +$13.5K +1,539 +127%
TSS
16
Two Sigma Securities
New York
$8.62K +$3.27K +373 +34%
PAG
17
Private Advisor Group
New Jersey
$8.22K – – –
HF
18
HRT Financial
New York
$8K +$13.3K +1,521 New
Millennium Management
19
Millennium Management
New York
$7.99K +$12K +1,365 New
MCC
20
Malaga Cove Capital
California
$7.04K +$10.5K +1,200 New
VF
21
Virtu Financial
New York
$7K -$13.8K -1,572 -58%
Commonwealth Equity Services
22
Commonwealth Equity Services
Massachusetts
$7K – – –
SFG
23
SNS Financial Group
Minnesota
$5.87K – – –
Osaic Holdings
24
Osaic Holdings
Arizona
$4.94K -$438 -50 -6%
FDCDDQ
25
Federation des caisses Desjardins du Quebec
Quebec, Canada
$2.94K – – –
1
2

EVGN Hedge Fund Activity: Q3 2023 in Review

35 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Evogene (EVGN) for Q3 2023, worth a combined $2.73M — up 260% from $760K a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new EVGN positions and 2 closed out — a net gain of 7 holders — while 10 added to existing stakes and 5 trimmed.

The largest buyer was Silverarc Capital Management, adding an estimated $2.63M. The largest seller was Jane Street, exiting entirely with an estimated $29.4K sold.

  • 35 institutional investors held Evogene (EVGN) as of Q3 2023, up from 28 in Q2 2023.
  • Funds reported $2.73M of Evogene stock for Q3 2023, up 260% quarter-over-quarter.
  • 9 funds opened new Evogene positions in Q3 2023 and 2 closed out, a net change of +7 holders.
  • The largest Evogene buyer in Q3 2023 was Silverarc Capital Management, an estimated $2.63M added.
  • The largest Evogene seller in Q3 2023 was Jane Street, an estimated $29.4K sold.

Based on aggregated 13F filings for Q3 2023.